|
DBI
News
|
| Company profile
|
DBI’s
aim is to provide each actor in the biotechnological research and the
pharmaceutical industry a production plant of small batches (till 8,000
vials and 20,000 syringes) of injectable, liquid or freeze-dried
products for highly potent drugs with:
•
Pharmaceutical company, M 12/203
•
A highly qualified team
•
Experienced in process transfer and scale up
•
Formulation under isolator
•
Filling, stoppering and capping under class A isolator
•
Total containment, no human intervention in sterile area
•
State of the art plant
•
State of the art equipment
•
Explosion proof, specific design for the filling line and the
lyophilizer
•
Environmental safety: specific cleaning |
|
|
|
 |
